AXT107 exhibited a dual mechanism of action as a monotherapy, disrupting a key component of the Vascular Endothelial Growth Factor...
SACRAMENTO, CA / ACCESSWIRE / March 18, 2019 / Falcon Technologies, Inc. (OTC PINK: FLCN) announced today its immediate entry...
CHESTER, NY / ACCESSWIRE / March 15, 2019 / Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) today...
Conference Call Scheduled for Today at 4:30 p.m. Eastern Time BERKELEY HEIGHTS, NJ / ACCESSWIRE / March 14, 2019 /...
ENGLEWOOD, CO / ACCESSWIRE / March 14, 2019 / Viveve Medical Inc. (NASDAQ: VIVE), a medical technology company focused on...
EDMONTON, AB / ACCESSWIRE / March 14, 2019 / Edmonton-based priMED Medical Products has been named one of Canada's Best...
NEW YORK, NY / ACCESSWIRE / March 14, 2019 / DNA Dynamics, Inc. (OTC PINK: DNAD) announces today that they...
COTTONWOOD HEIGHTS, UT / ACCESSWIRE / March 14, 2019 / Dynatronics Corporation (NASDAQ: DYNT), a leading provider of physical therapy,...
SOUTH SAN FRANCISCO, CA / ACCESSWIRE / March 14, 2019 / VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing...
Launch Places DECN at the Top of Tier in the Fast Growing Pet Testing Market with Both Proprietary Products and...
Data to be Presented on Ongoing Natesto Spermatogenesis Study, Study Evaluating the Effect of Natesto Nasal Testosterone on Male Fertility...
VANCOUVER, BC / ACCESSWIRE / March 14, 2019 / EViTRADE Health Systems Corp. (CSE: EVA, OTCQB: EVAHF) (the "Company") is...
ALACHUA, FL / ACCESSWIRE / March 14, 2019 / CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that...
CAMPBELL, CA / ACCESSWIRE / March 14, 2019 / VIVUS, Inc. (NASDAQ: VVUS; the "Company"), a biopharmaceutical company, today announced...
HOUSTON, TX / ACCESSWIRE / March 14, 2019 / Soliton, Inc., (NASDAQ: SOLY) (''Soliton'' or the ''Company''), a medical device...
LOS ANGELES, CA / ACCESSWIRE / March 14, 2019 / Decision Diagnostics Corp. (OTC PINK: DECN) Decision Diagnostics Corp. is...
Conference call and webcast (in English) tomorrow, March 14, 2019 at 2:00pm CET (1:00pm GMT/9:00am EDT)Highlights in R&D and corporate...
On-Track to Report Top Line Results from Pivotal Phase 3 IMPALA Study at End of Q2 2019 AUSTIN, TX /...
TORONTO, ON / ACCESSWIRE / March 13, 2019 / Easton Pharmaceuticals Inc. (OTC PINK: EAPH) Provides Update on Its $2,600,000...
86,000 square foot planned cultivation facility expected to produce 28000 pounds of flower annually LAS VEGAS, NV / ACCESSWIRE /...